Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

NCT01148628 is registered in ClinicalTrials.gov with Southern Europe New Drug Organization as lead sponsor.

NCT NCT01148628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01148628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors
Lead sponsor
Southern Europe New Drug Organization
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2007
Completion date
December 31, 2011
Enrollment
54 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors